Effectiveness and Safety of Atelocollagen in the Management of Chronic Non-specific Low Back Pain

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

March 3, 2022

Study Completion Date

April 27, 2022

Conditions
Low Back Pain
Interventions
DEVICE

atelocollagen

"This collagen-contained product is used to supplement tendon, ligament, muscle, and (biological) membrane that is missing or damaged during internal/surgical treatment and surgery.~Patients with chronic low back pain are randomized after obtaining informed consent for the study.~Participants are divided into group A (atelocollagen) and group B (control). A physical examination for lumbar pain was performed and evaluated trigger points in multifidus, erector spinae, and quadratus lumborum muscles.~After physical exam, cross sectional area of each muscle is measured by ultrasound in both gorup.~Group A will receive atelocollagen mixture (atelocollagen 3 mL + 1% lidocaine 3 mL) and group B will receive local anesthetics only (Normal saline 3 mL + 1% lidocaine 3 mL).~Each participants will be injected 1 mL of injectate into each muscle on both sides (total 6 mL)."

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University

OTHER